|
Carmona-Bayonas A, Jimenez-Fonseca P, Gallego J, Msaouel P. Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries. Cancer Invest. 2022 Jan;40(1):1-13. doi: 10.1080/07357907.2021.1999971. Epub 2021 Nov 25. PubMed PMID: 34709109.
AÑO: 2022; IF: 2.4
|
34709109
|
Jimenez-Fonseca P, Gallardo E, Arranz Arija F, Blanco JM, Callejo A, Lavin DC, Costa Rivas M, Mosquera J, Rodrigo A, Sanchez Morillas R, Vares Gonzalez M, Munoz A, Carmona-Bayonas A. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence. Eur J Intern Med. 2022 Jun;100:33-45. doi: 10.1016/j.ejim.2022.02.020. Epub 2022 Feb 26. PubMed PMID: 35227541.
AÑO: 2022; IF: 8.0
|
|
Perez-Hernandez C, Canovas ML, Carmona-Bayonas A, Escobar Y, Margarit C, Mulero Cervantes JF, Quintanar T, Serrano Alfonso A, Virizuela J. A Delphi Study on the Management of Neuropathic Cancer Pain in Spain: The DOLNEO Study. J Pain Res. 2022 Aug 2;15:2181-2196. doi: 10.2147/JPR.S365351. eCollection 2022. PubMed PMID: 35942117; PubMed Central PMCID: PMC9356710.
AÑO: 2022; IF: 2.7
|
|
Msaouel P, Jimenez-Fonseca P, Lim B, Carmona-Bayonas A, Agnelli G. Medicine before and after David Cox. Eur J Intern Med. 2022 Apr;98:1-3. doi: 10.1016/j.ejim.2022.02.022. Epub 2022 Feb 28. PubMed PMID: 35241350.
AÑO: 2022; IF: 8.0
|
|
Valenti V, Jimenez-Fonseca P, Msaouel P, Salazar R, Carmona-Bayonas A. Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit. Cancer Invest. 2022 Feb;40(2):184-188. doi: 10.1080/07357907.2021.2020281. Epub 2021 Dec 27. PubMed PMID: 34919008.
AÑO: 2022; IF: 2.4
|